Picture of EssilorLuxottica SA logo

EL EssilorLuxottica SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

France's EssilorLuxottica FY revenue rises

Overview

France eyewear giant's FY revenue grew 11.2%, beating analyst expectations

Adjusted operating margin at 16% impacted by US tariffs and AI-glasses

AI-glasses sold over 7 mln units in FY, boosting company performance

Outlook

EssilorLuxottica plans solid revenue growth over next five years at constant exchange rates

Company expects adjusted operating profit growth aligned with revenue growth

Result Drivers

AI-GLASSES SALES - Co sold over 7 mln units of AI-glasses in FY, contributing significantly to revenue growth

MYOPIA MANAGEMENT - Myopia management portfolio revenue increased by 22% worldwide, indicating strong demand

REGIONAL GROWTH - North America, EMEA, and Asia-Pacific regions all reported double-digit growth in Q4 and FY

Key Details

MetricBeat/MissActualConsensus Estimate
FY RevenueBeatEUR 28.49 blnEUR 28.04 bln (20 Analysts)
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell" The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy" Wall Street's median 12-month price target for EssilorLuxottica SA is €333.50, about 33.1% above its February 10 closing price of €250.50 The stock recently traded at 33 times the next 12-month earnings vs. a P/E of 41 three months ago Press Release: ID:nGNEb5bMZn For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on EssilorLuxottica SA

See all news